par Sacco, Ralph L.;Diener, Hans-Christoph;Yusuf, Salim;Cotton, Daniel;Ounpuu, Stephanie;Lawton, William A;Palesch, Yuko;Martin, Ricardo;Albers, Gregory W;Bath, Philip;Bornstein, Natan;Chan, Bernard PL;Chen, Sien-Tsong;Cunha, Luis;Dahlöf, Björn;De Keyser, Jacques;Donnan, Geoffrey A;Estol, Conrado;Gorelick, Philip;Gu, Vivian;Hermansson, Karin;Hilbrich, Lutz;Kaste, Markku;Lu, Chuanzhen;Machnig, Thomas;Pais, Prem;Roberts, Robin;Skvortsova, Veronika;Teal, Philip;Toni, Danilo;VanderMaelen, Cam;Voigt, Thor;Weber, Michaël;Yoon, Byung-Woo;PRoFESS Study Group, Massimo;Pandolfo, 
Référence The New England journal of medicine, 359, 12, page (1238-1251)
Publication Publié, 2008-09
Référence The New England journal of medicine, 359, 12, page (1238-1251)
Publication Publié, 2008-09
Article révisé par les pairs
| Titre: |
|
| Auteur: | Sacco, Ralph L.; Diener, Hans-Christoph; Yusuf, Salim; Cotton, Daniel; Ounpuu, Stephanie; Lawton, William A; Palesch, Yuko; Martin, Ricardo; Albers, Gregory W; Bath, Philip; Bornstein, Natan; Chan, Bernard PL; Chen, Sien-Tsong; Cunha, Luis; Dahlöf, Björn; De Keyser, Jacques; Donnan, Geoffrey A; Estol, Conrado; Gorelick, Philip; Gu, Vivian; Hermansson, Karin; Hilbrich, Lutz; Kaste, Markku; Lu, Chuanzhen; Machnig, Thomas; Pais, Prem; Roberts, Robin; Skvortsova, Veronika; Teal, Philip; Toni, Danilo; VanderMaelen, Cam; Voigt, Thor; Weber, Michaël; Yoon, Byung-Woo; PRoFESS Study Group, Massimo; Pandolfo, |
| Informations sur la publication: | The New England journal of medicine, 359, 12, page (1238-1251) |
| Statut de publication: | Publié, 2008-09 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Aged |
| Angiotensin-Converting Enzyme Inhibitors -- therapeutic use | |
| Aspirin -- administration & dosage | |
| Aspirin -- adverse effects | |
| Benzimidazoles -- therapeutic use | |
| Benzoates -- therapeutic use | |
| Brain Ischemia -- epidemiology | |
| Brain Ischemia -- prevention & control | |
| Delayed-Action Preparations | |
| Dipyridamole -- adverse effects | |
| Dipyridamole -- therapeutic use | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Factor Analysis, Statistical | |
| Female | |
| Hemorrhage -- chemically induced | |
| Humans | |
| Kaplan-Meiers Estimate | |
| Male | |
| Middle Aged | |
| Myocardial Infarction -- epidemiology | |
| Platelet Aggregation Inhibitors -- administration & dosage | |
| Platelet Aggregation Inhibitors -- adverse effects | |
| Platelet Aggregation Inhibitors -- therapeutic use | |
| Proportional Hazards Models | |
| Recurrence -- prevention & control | |
| Risk | |
| Stroke -- drug therapy | |
| Stroke -- epidemiology | |
| Stroke -- prevention & control | |
| Ticlopidine -- adverse effects | |
| Ticlopidine -- analogs & derivatives | |
| Ticlopidine -- therapeutic use | |
| Vascular Diseases -- mortality | |
| Note générale: | Comparative Study |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0028-4793 |
| info:doi/10.1056/NEJMoa0805002 | |
| info:pii/NEJMoa0805002 | |
| info:pmid/18753638 | |
| PMC2714259 |
